Early detection of disease can mean the difference between life and death for a person, especially in the case of serious illness. Technology has helped identify several new tools that aid doctors and patients diagnose diseases at a very early stage, thus reducing mortality rates. One such development in the field of medical science is vocal biomarker. A biomarker can be referred as a symptom or medical condition of the human body. In the case of vocal biomarkers, it is the pattern of voice. Vocal biomarkers market has been growing at a steady pace in the past few years and is expected to reap phenomenal growth in the coming years.
The global vocal biomarkers market is segmented on the basis of type, end user, and indications. Under the type segment, the market tis further classified into error rate, frequency, amplitude, pitch, phonation time, voice rise or fall time, and voice tremor. Based on end-users, it is sub-divided into hospitals, laboratories, research facilities, and other organizations.
Vocal biomarkers have several advantages that augment its demand in the market. One of the most important factors is the need for early detection of diseases, especially from developed and developing countries. Further, it is one of the most cost-efficient techniques for diseases detection today. These two factors primarily are predicted to stem growth in the global vocal biomarkers market.
Pharmaceutical companies across the globe are eyeing potential from vocal biomarkers as they help in detecting psychiatric and neurological disorders. Some conditions like Parkinson’s, Alzheimer’s, and Schizophrenia come to light at a later stage of the disease which restricts doctors from adopting stringent treatment measures. For players in the pharmaceutical industry, vocal biomarkers can help early diagnosis, thus promoting sales for their drugs.
Besides healthcare, vocal biomarkers also find applications in detecting lie. They are highly useful in defense organization and security agencies while questioning a criminal. Officials with international security agencies have pointed out that vocal biomarkers account for 38% of the analysis in a lie detection test. This is a vital factor to propel demand for vocal biomarkers in the coming years.
The global vocal biomarkers market is setting its foot in multiple geographies. North America, the region with the highest technological and healthcare advancements, is the largest shareholder of the vocal biomarkers market. Besides health, the increasing focus on national security and continuing to remain the world superpower, pushes demand for vocal biomarkers in the defense sector too. Europe is also equally important for the global vocal biomarkers market. What attracts existing players is the expected rise in demand from Asia Pacific. As countries like India and China strengthen their defense and healthcare setups, the demand for vocal biomarkers will also rise.
The fast-developing research set up in the existing players is instilling intense competition in the global vocal biomarkers market. Some of the prominent players include IBM Corporation, Audio Profiling, Cogito Corporation, Sonde Health, and Beyond Verbal. These companies are also attentive about interesting research developments in the vocal biomarkers space, and are keen on acquiring these technologies to bring uniqueness to their product line.
Type
Indications
End users
Geography
N/A
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Vocal Biomarkers Market
*86 figures and 60 tables includes